First series: Friday, April 2, 2021. Please see below details of the conference
Date: August 5, 2021
Time: 5:30 pm – 7 pm (PDT)
PLATFORM USE: WHOVA
1st Lecture & Discussion
TOPIC: SSC-ILD: WHEN SYSTEMIC SCLEROSIS AFFECTS THE LUNG
KEYNOTE SPEAKER: Elizabeth R. Volkmann, MD, MS Medicine, Rheumatology, Ronald Reagan UCLA Medical Center
2nd Lecture & Discussion
TOPIC: THE CURRENT STATE OF OFEV® (NINTEDANIB) IN SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE
KEYNOTE SPEAKER: Chase S. Correia, MD, Assistant Professor of Medicine (Rheumatology) Northwestern University Feinberg School of Medicine
5:30 Business Meeting
5:40 Advocacy Report
6:00 1st Lecture Elizabeth Volkmann, MD, MS & Discussion
6:45 Meet & Greet SCRS Exhibitors
7:15 2nd Lecture Chase Correia, MD & Discussion
8:00 Closing Remarks
Please register no later than Aug 3, 2021 by emailing:
We hope you that you and your loved ones all find yourselves well during these uncertain times. I wanted to provide an update regarding where we stand with our meetings. At this time, we have no plans to restart our in-person meetings for the safety of our members and we will update you all when it seems safe to do so. I wanted to gauge whether there would be any interest in a WebEx or Zoom style meeting and if so, are there any particular topics of interest. Please send replies to Mara regarding this. Thank you.
A few other items, regarding COVID-19 in our rheumatology population. If you are not yet doing so, please consider either sharing your experience or adding your patient to the COVID-19 Global Rheumatology Alliance website https://rheum-covid.org/
For additional guidance on therapy for our rheumatology patients, please see the ACR’s published COVID-19 clinical guidance for adult patients with rheumatic disease. https://rheum-covid.org/
I also want to make sure that providers are aware that the Department of Health and Human services has relief funds created by the CARES Act approving $100 billion to hospitals, physicians and other healthcare providers for lost revenues. This is the link to their guide with FAQ’s and to submit your application if you have not already done so. https://chameleoncloud.io/review/2977-5ea0af98f0fd0/prod. The ACR does have email assistance for questions you may have. Please email email@example.com or visit the American College of Rheumatology website under their COVID-19 section.
If any of you are currently involved in the management of cytokine storm in COVID-19 patients and would like to share your experience or if you have participated in protocol/treatment algorithm development using biologics for COVID19 patients we would like to know- please send replies to firstname.lastname@example.org.
We are providing here a letter penned by Dr. Vaneet Sandhu of Loma Linda University Division of Rheumatology and recently published in the Journal of Rheumatology discussing rheumatologists role in this current pandemic. (please see attached PDF).
If you have any recent publications relating to COVID-19, please share with us so we can all learn from each other.
Feel free to reach out to us with any questions or concerns, we enjoy hearing from you all. Thank you for all you do for our patients. Stay safe and we hope to see you all in person soon enough.
Rhina D. Castillo M.D.
President for the Southern California Rheumatology Society
The mission of the Southern California Rheumatology Society (SCRS) is to provide an ethical and educational forum for its members concerning recent scientific advances in the field and practice of Rheumatology and related medical specialties.